BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21028953)

  • 1. Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use.
    Merki-Feld GS; Hund M
    Eur J Contracept Reprod Health Care; 2010 Dec; 15(6):413-22. PubMed ID: 21028953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with NuvaRing in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages.
    Merki-Feld GS; Hund M
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):240-7. PubMed ID: 17763262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
    Sarkar NN
    Eur J Contracept Reprod Health Care; 2005 Jun; 10(2):73-8. PubMed ID: 16147810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.
    Barreiros FA; Guazzelli CA; de Araújo FF; Barbosa R
    Contraception; 2007 Mar; 75(3):204-8. PubMed ID: 17303490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended regimens of the vaginal contraceptive ring: cycle control.
    Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF
    Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraceptive vaginal ring.
    Madden T; Blumenthal P
    Clin Obstet Gynecol; 2007 Dec; 50(4):878-85. PubMed ID: 17982330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contraceptive vaginal ring.
    Edwardson J; Jamshidi R
    Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands.
    Roumen FJ; op ten Berg MM; Hoomans EH
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):14-22. PubMed ID: 16546812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series.
    Calhoun A; Ford S; Pruitt A
    Headache; 2012 Sep; 52(8):1246-53. PubMed ID: 22789073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
    Dieben TO; op ten Berg MT; Coelingh Bennink HJ
    Arzneimittelforschung; 1994 Jul; 44(7):877-9. PubMed ID: 7945527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High acceptability and satisfaction with NuvaRing use.
    Szarewski A
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():31-6; discussion 37-9. PubMed ID: 12659400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the vaginal contraceptive ring (NuvaRing).
    Shimoni N; Westhoff C
    J Fam Plann Reprod Health Care; 2008 Oct; 34(4):247-50. PubMed ID: 18854070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.
    Roumen F
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():19-24; discussion 37-9. PubMed ID: 12659398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower hormone dosage with improved cycle control.
    Vree M
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():25-30; discussion 37-9. PubMed ID: 12659399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
    Bruni V; Pontello V; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined hormonal contraception in cycles artificially extended].
    Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
    Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction.
    Roumen FJ; Mishell DR
    Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):415-27. PubMed ID: 23113828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results.
    Paternoster DM; Riboni F; Bertolino M; Garofalo G; Lazzarich E; Surico N; Stratta P
    Transplant Proc; 2010 May; 42(4):1162-5. PubMed ID: 20534250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
    Massai R; Mäkäräinen L; Kuukankorpi A; Klipping C; Duijkers I; Dieben T
    Hum Reprod; 2005 Oct; 20(10):2764-8. PubMed ID: 15980008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.